Dose Optimization Study of Idelalisib in Follicular Lymphoma

Clinical trial NCT02536300 · TERMINATED

Trial details

NCT number: NCT02536300
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2016-01-14
Primary completion: 2022-09-27
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.